Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03966859Completed
Randomised, double-blind trial in major depressive disorder (MDD) comparing Placebo with Atorvastatin (2 arms). Primary endpoints: Accuracy during facial expression recognition task at Day 8, Reaction times during facial expression recognition task at Day 8 and 7 more. Started Jun 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03966859.